Endonovo Therapeutics, Inc. (ENDV) stock
ENDVOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2023, quarter ended Sep 30, 2023Last filing: 10-Q/A on Dec 29, 2023
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $135.08KP/E –Yield –
Endonovo Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Endonovo Therapeutics's enterprise value was $31.88K on Oct 19, 2026, against $63.75K a year earlier. Over the last 5 years it ranged from $319 to $3.99M, with a median of $663.83K.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $31.88K | 0.0% |
| 2025 | Dec 31, 2025 | $31.88K | -75.0% |
| 2024 | Dec 31, 2024 | $127.50K | -95.4% |
| 2023 | Dec 29, 2023 | $2.77M | -2.5% |
| 2022 | Dec 30, 2022 | $2.84M | +164.8% |
| 2021 | Dec 31, 2021 | $1.07M | +211.0% |
| 2020 | Dec 31, 2020 | $345.23K | -100.0% |
| 2019 | Dec 31, 2019 | $1.59B | -77.2% |
| 2018 | Dec 31, 2018 | $6.94B | -57.9% |
| 2017 | Dec 29, 2017 | $16.48B | +164.6% |
| 2016 | Dec 30, 2016 | $6.23B | -82.1% |
| 2015 | Dec 31, 2015 | $34.73B | +3238.0% |
| 2014 | Dec 31, 2014 | $1.04B | -99.6% |
| 2013 | Dec 31, 2013 | $235.07B | – |
See a number that looks wrong?